IP Library › Granted Patent US 9,795,537
Granted Patent B2
US 9,795,537 · App. 14/938,829 · Granted Oct 24, 2017

Topical pharmaceutical compounds and methods

Inventors: Austin Bonderer (Fullerton, CA); Clark Levi (Ocean Springs, MS)
A61J3/00A61J1/18A61K31/135A61K31/167A61K31/192A61K31/522
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,795,537
App. No.
14/938,829
Granted
Oct 24, 2017
Kind
B2
Abstract

Methods to enable a visual check on the mixing proper pharmaceutical compounding kits. The methods include providing a kit with a colored inactive to be added to the mixture. When the mixture is uniform or resembles a predetermined color, the mixture is assumed to be properly mixed.

Claims (33)

1. A method comprising:

providing a kit comprising:

a mixing container;

a colored inactive;

a first active ingredient located in a first active ingredient container; and

an inactive ingredient located in an inactive ingredient container;

placing the first active ingredient, the colored inactive, and the inactive ingredient in the mixing container; and

mixing the first active ingredient, the colored inactive, and the inactive ingredient in the mixing container;

wherein the first active ingredient is a drug.

2. The method of claim 1 , wherein the mixing is done until a substantially uniform color is obtained.

3. The method of claim 1 , wherein the kit further comprises instructions, and the instructions comprise a finish color; and the mixing is done until contents of the mixing container resemble the finish color.

4. The method of claim 1 , wherein both the first active ingredient and the colored inactive is powdered form.

5. The method of claim 1 , wherein the colored inactive is a color that is different than the first active ingredient and the inactive ingredient.

6. A method comprising:

providing a kit comprising:

a colored inactive;

a first active ingredient located in a first active ingredient container; and

an inactive ingredient located in an inactive ingredient container placing the first active ingredient and the colored inactive in the inactive ingredient container;

mixing the first active ingredient the colored inactive and the inactive ingredient in the inactive ingredient container;

wherein the first active ingredient is a drug.

7. The method of claim 6 , wherein the mixing is done until contents of the inactive ingredient container are uniform.

8. The method of claim 6 , wherein the kit further comprises instructions and the instructions comprise a finish color; and the mixing is done until contents of the mixing container resemble the finish color.

9. The method of claim 6 , wherein both the first active ingredient and the colored inactive is powdered form.

10. The method of claim 6 , wherein the colored inactive is a color that is different than the first active ingredient and the inactive ingredient.

11. A method comprising:

providing a kit comprising:

a colored inactive;

a first active ingredient, wherein the first active ingredient is a drug; and

an inactive ingredient; and

mixing the colored inactive, the first active ingredient and the inactive ingredient in a container until contents of the container appear uniform.

12. The method of claim 11 , wherein the kit further comprises instructions and the instructions comprise a finish color; and the mixing is done until contents of the mixing container resemble the finish color.

13. The method of claim 11 , wherein both the first active ingredient and the colored inactive is powdered form.

14. The method of claim 11 , wherein the colored inactive is a color that is different than the first active ingredient and the inactive ingredient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2018
From: BONDERER, AUSTIN; LEVI, CLARK
To: C-LAB, LLC
Reel/Frame 047596/0908 →
Continuity (3)
Division 13828152 · Mar 14, 2013
Provisional Application 61614708 · Mar 23, 2012
Related Publication 20160058669A1 · Mar 3, 2016